[1] 朱书彤, 赵 越. PPARα在肝脏相关疾病中作用的研究进展[J]. 生命科学, 2017(5): 479-484. [2] Araki M, Nakagawa Y, Oishi A, et al. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist pemafibrate protects against diet-induced obesity in mice[J]. Int J Mol Sci, 2018, 19(7): 2148. [3] Smith BK, Steinberg GR.AMP-activated protein kinase, fatty acid metabolism, and insulin sensitivity[J]. Curr Opin Clin Nutr Metab Care, 2017, 20(4): 248-253. [4] Kim B, Woo MJ, Park CS, et al. Hovenia dulcis extract reduces lipid accumulation in oleic acid-induced steatosis of Hep G2 cells via activation of AMPK and PPARalpha/CPT-1 pathway and in acute hyperlipidemia mouse model[J]. Phytother Res, 2017, 31(1): 132-139. [5] 曹家凌, 肖国强. 运动训练和辛伐他汀对肥胖大鼠脂质代谢及肝脏PPARα表达的影响[J]. 西安体育学院学报, 2016, 33(2): 218-225. [6] Kim K, Boo K, Yu YS, et al. RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network[J]. Nature Communications, 2017, 8(1): 162. [7] Zheng F, Cai Y. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet[J]. Lipids Health Dis, 2019, 18(1): 6. [8] Corrales P, Vidal-Puig A, Medina-Gomez G. PPARs and metabolic disorders associated with challenged adipose tissue plasticity[J]. Int J Mol Sci, 2018, 19(7): 2124. [9] Batatinha HA, Lima EA, Teixeira AA, et al. Association between aerobic exercise and rosiglitazone avoided the NAFLD and liver inflammation exacerbated in PPAR-alpha knockout mice[J]. J Cell Physiol, 2017, 232(5): 1008-1019. [10] Takahashi H, Sanada K, Nagai H, et al. Over-expression of PPARα in obese mice adipose tissue improves insulin sensitivity[J]. Biochem Biophys Res Commun, 2017, 493(1): 108-114. [11] 李 蕾. 运动对高脂饲料喂养大鼠骨骼肌和肝脏组织脂联素-脂联素受体-腺苷酸活化蛋白激酶通路的影响[J]. 中国应用生理学杂志, 2016, 32(2): 109-111. [12] 朱天逸, 张蕴琨. 运动对大鼠肝脏FFA、PPARα和CPT-1的影响[J]. 南京体育学院学报, 2017, 16(4): 39-43. [13] Lin X, Yang Y, Qu J, et al. Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARgamma[J]. Nutr Metab (Lond), 2019, 16(1): 17. [14] 王天源. PPARα在有氧运动改善肥胖、糖尿病和动脉粥样硬化大鼠血糖血脂中的作用及其与PPARγ的关系[D]. 上海体育学院, 2019. [15] Zhang Y, Cui Y, Wang XL, et al. PPARalpha/gamma agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats[J]. Cytokine, 2015, 75(1): 127-135. [16] Lehrke M, Lazar MA.The many faces of PPARgamma[J]. Cell, 2005, 123(6): 993-999. [17] Elmazar MM, Elabhar HS, Schaalan MF, et al. Phytol/phytanic acid and insulin resistance: Potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations[J]. Plos One, 2013, 8(1): e45638. [18] Liu Y, Cheng F, Luo Y, et al. PEGylated curcumin derivative attenuates hepatic steatosis via CREB/PPAR-γ/CD36 pathway[J]. Biomed Res Int, 2017, 2017(1): 1-11. [19] 李毛毛, 黄鑫源, 梁乾坤, 等. 荷叶水提物对实验性肥胖大鼠脂代谢的影响及机制[J]. 中国应用生理学杂志, 2017, 33(5): 476-480. [20] Fryer LGD, Asha PP, David C.The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways[J]. J Biol Chem, 2002, 277(28): 25226-25232. [21] Piche ME, Laberge AS, Brassard P, et al. Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study[J]. Diabetes Obes Metab, 2018, 20(7): 1740-1750. [22] Abd El-Haleim EA, Bahgat AK, Saleh S.Effects of combined PPAR-gamma and PPAR-alpha agonist therapy on fructose induced NASH in rats: Modulation of gene expression[J]. Eur J Pharmacol, 2016, 773: 59-70. |